Bharat Biotech, SII arm Bilthoven Biologicals join hands for global polio eradication – Times of India

[ad_1] HYDERABAD: Vaccine maker Bharat Biotech has joined hands with Serum Institute of India’s (SII) wholly-owned Dutch subsidiary Bilthoven Biologicals BV (BBio) for the procurement of drug substances for the production of oral polio vaccines for the Indian as well as global markets.Bharat Biotech and Bilthoven Biologicals, who have entered into an agreement, will jointly…

Read More

Bharat Biotech begins clinical trials of TB vaccine on adults in India – Times of India

[ad_1] HYDERABAD: Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri, a press release from Bharat Biotech said. The release said that Mtbvac is being developed…

Read More